title: Permeation of human ovarian tissue with cryoprotective agents in preparation for cryopreservation.
abstract: The recent improvements in the treatment of cancer by chemo- and radiotherapy have led to a significant increase in the survival rates of patients with malignant disease, but at the expense of distressing side effects. One major problem, especially for younger patients, is that aggressive therapy destroys a significant proportion of the follicular population, which can result in either temporary or permanent infertility. Freeze-banking pieces of ovarian cortex prior to treatment is one strategy for preserving fecundity. When the patient is in remission, fertility could, theoretically, be restored by autografting the thawed tissue at the orthotopic site or by growing isolated follicles to maturity in vitro. Recent studies have found good follicular survival in frozen-thawed human ovarian tissue but to optimize the process an effective cryopreservation method needs to be developed. An essential part of such a technique is to permeate the tissue with a cryoprotectant to minimize ice formation and the extent of this equilibration is an important determinant of post-thaw cellular survival. In the current study, we have investigated the diffusion of four cryoprotective agents into human tissue at both 4 degrees C and 37 degrees C. We have also studied the effect of adding different concentrations of the non penetrating cryoprotective agent, sucrose, to the freezing media using the release of lactate dehydrogenase as a measure of its protective effect. At 4 degrees C propylene glycol and glycerol penetrated the tissue significantly slower than either ethylene glycol or dimethyl sulphoxide. At the higher temperature of 37 degrees C all four cryoprotectants penetrated at a faster rate, however concern about enhanced toxicity prevents the use of these conditions in practice. Thus, the results suggest that the best method of preparing tissue for freezing is exposure for 30 min to 1.5 M solutions of ethylene glycol or dimethyl sulphoxide at 4 degrees C; this achieved a mean tissue concentration that was almost 80% that of the bathing solution. We also report that the addition of low concentrations of sucrose to the freezing medium does not have a significant protective effect against freezing injury.
authors.affiliation: Centre for Reproduction, Growth and Development, School of Clinical Medicine, University of Leeds, Leeds General Infirmary, UK.
authors.forename: H
authors.initials: H
authors.lastname: Newton
authors.forename: J
authors.initials: J
authors.lastname: Fisher
authors.forename: J R
authors.initials: JR
authors.lastname: Arnold
authors.forename: D E
authors.initials: DE
authors.lastname: Pegg
authors.forename: M J
authors.initials: MJ
authors.lastname: Faddy
authors.forename: R G
authors.initials: RG
authors.lastname: Gosden
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects; D015925:Cryopreservation / Q000379:methods*; D003451:Cryoprotective Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004121:Dimethyl Sulfoxide / Q000008:administration & dosage / Q000493:pharmacokinetics; D019855:Ethylene Glycol / Q000008:administration & dosage / Q000493:pharmacokinetics; D005260:Female; D005990:Glycerol / Q000008:administration & dosage / Q000493:pharmacokinetics; D006801:Humans; D066298:In Vitro Techniques; D007247:Infertility, Female / Q000209:etiology / Q000517:prevention & control; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy; D010053:Ovary / Q000187:drug effects / Q000293:injuries / Q000378:metabolism; D010539:Permeability; D019946:Propylene Glycol / Q000008:administration & dosage / Q000493:pharmacokinetics
chemical_list: D000970:Antineoplastic Agents; D003451:Cryoprotective Agents; D019946:Propylene Glycol; D007770:L-Lactate Dehydrogenase; D019855:Ethylene Glycol; D005990:Glycerol; D004121:Dimethyl Sulfoxide